Finoriq research workspace
Armata Pharmaceuticals, Inc. (ARMP) Historical Metrics
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the. Review ARMP valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
- Company
- Armata Pharmaceuticals, Inc. (ARMP)
- Ticker
- ARMP
- Market Cap
- $183.6M
- Latest Price
- $5.00
- Industry
- Biotech & Pharma
Armata Pharmaceuticals, Inc. (ARMP) Current Valuation Metrics
Static valuation preview for Armata Pharmaceuticals, Inc. (ARMP). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -160.0% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -13.6% | Operating Cash Flow | TTM Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.